Found: 1
Select item for more details and to access through your institution.
Ixazomib plus daratumumab and dexamethasone: Final analysis of a phase 2 study among patients with relapsed/refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 9, p. 1746, doi. 10.1002/ajh.27382
- By:
- Publication type:
- Article